Cancer Risk Assessment | PhenoTips
BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors | Genetics in Medicine
Applicability and ease of use of risk assessment models. | Download Table
BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface | British Journal of Cancer
BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors | Genetics in Medicine
The BOADICEA Project – translational research in practice - ppt download
BOADICEA Risk Model - FamGenix
Breast cancer risk evaluation for the primary care physician | Cleveland Clinic Journal of Medicine
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Recommendation Statement | AAFP
Karma TYRER-CUZICK and BOADICEA variables
Breast Cancer Risk Assessment: Calculating Lifetime Risk Using the Tyrer-Cuzick Model - ScienceDirect
Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: A multi-methods study | PLOS ONE
Mathematical Model Predicts Breast Cancer Risk in Women
Genetics of Breast and Gynecologic Cancers (PDQ®)–Health Professional Version - NCI
Personalised Risk Prediction in Hereditary Breast and Ovarian Cancer: A Protocol for a Multi-Centre Randomised Controlled Trial
10-year performance of four models of breast cancer risk: a validation study - The Lancet Oncology
Variability Among Breast Cancer Risk Classification Models When Applied at the Level of the Individual Woman | SpringerLink
Valoración de riesgo y medidas de prevención en cáncer hereditario
Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: A multi-methods study | PLOS ONE
Breast Cancer Risk Assessment: Calculating Lifetime Risk Using the Tyrer-Cuzick Model - ScienceDirect
Valoración de riesgo y medidas de prevención en cáncer hereditario
Validation of breast cancer risk assessment tools on a French-Canadian population-based cohort | BMJ Open
Decision aid for breast cancer risk stratification. The percentages... | Download Scientific Diagram
Risk Evaluator Software
Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: A multi-methods study | PLOS ONE
It's not time to abandon routine screening mammography in average-risk women in their 40s | MDedge ObGyn
